Back to Search
Start Over
1788P Association between deep prostate-specific antigen decline and survival in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial.
- Source :
-
Annals of Oncology . 2023 Supplement 2, Vol. 34, pS966-S967. 2p. - Publication Year :
- 2023
- Subjects :
- *PROSTATE-specific antigen
*OVERALL survival
*PROSTATE cancer
*METASTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173099394
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.09.2738